Beryllium, a company comprised of drug discovery professionals applying integrated expertise to tackle promising drug targets emerging from human biology and genetics, announced today that Dalia Cohen, Ph.D., Head of Research, and Arturo J. Morales, Ph.D., Vice President, Informatics, will chair two sessions at the 2015 Molecular Medicine Tri-Conference in San Francisco. The conference is being held February 15-20, 2015 at the Moscone Convention Center. Details on the two sessions include:
Help employers find you! Check out all the jobs and post your resume.
